NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 136 filers reported holding NEKTAR THERAPEUTICS in Q2 2013. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $22,035,000 | -5.8% | 1,825,600 | 0.0% | 1.12% | +2.0% |
Q2 2014 | $23,404,000 | +5.8% | 1,825,600 | 0.0% | 1.10% | +1.1% |
Q1 2014 | $22,126,000 | +6.8% | 1,825,600 | 0.0% | 1.09% | +8.5% |
Q4 2013 | $20,721,000 | +8.6% | 1,825,600 | 0.0% | 1.00% | +32.4% |
Q3 2013 | $19,078,000 | -9.5% | 1,825,600 | 0.0% | 0.76% | -19.7% |
Q2 2013 | $21,086,000 | – | 1,825,600 | – | 0.94% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
CM Management, LLC | 50,000 | $160,000 | 0.18% |
TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |